NCT06011980

Life-2023-02 Esophagogastric Variceal Bleeding

Life-2023-02 Study on the Efficacy of Growth Inhibitors After Endoscopic Treatment of Acute Esophagogastric Variceal Bleeding

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 33 (estimated)
• Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

Study on the efficacy of the growth inhibitors after endoscopic treatment of acute esophagogastric variceal bleeding

Detailed description

Participants with acute esophagogastric variceal bleeding in 5 days and under stable status will be included in this study. All the patients will take CTP test to confirm the blood flow status of the portal vein before endoscopic treatment. After that they will be randomly divided into two groups: A. accept growth inhibitors after the endoscopic treatment for 5 days; B. no growth inhibitor will be applied after the treatment.

Conditions

• Acute Esophageal Variceal Hemorrhage

Interventions

Type	Name	Description
DRUG	Growth Inhibitor	growth inhibitors for 250-500μg/h, ivgtt. for 5 days

Timeline

• Start date: 2023-08-01
• Primary completion: 2026-05-10
• Completion: 2026-08-10
• First posted: 2023-08-25
• Last updated: 2023-08-25

Locations

1 site across 1 country: China